AZN vs INSM · P/E 28, $288.38B cap vs rev $731.5M
AstraZeneca PLC (AZN) versus Insmed Inc (INSM) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Insmed Inc (INSM) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported INSM revenue for 2026-06-30 was $731.5M. Net income was -$176.8M. INSM currently screens at market cap $20.42B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. INSM currently screens at market cap $20.42B.
Not investment advice. Open the AZN and INSM stock pages for the full models.
Not investment advice.